Navigation Links
Reliable biomarkers needed for early detection of liver cancer
Date:2/25/2010

While biomarkers are needed to complement ultrasound in the early detection of hepatocellular carcinoma (HCC; liver cancer), neither des-gamma-carboxy prothrombin (DCP) nor the most widely used biomarker, alpha fetoprotein (AFP), is optimal, according to a new study in Gastroenterology, the official journal of the American Gastroenterological Association (AGA) Institute.

"Most surprising was the finding that patient demographics influenced both des-gamma-carboxy prothrombin and alpha fetoprotein values, but in opposite directions," said Anna S. Lok, MD, AGAF, of the University of Michigan Medical Center and lead author of the study. "This observation merits further investigation, as it might impact the accuracy of these biomarkers in the detection of liver cancer."

The study was conducted in 10 centers in the U.S. and funded by the National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health.

Among 1,031 patients randomized in the Hepatitis C Antiviral Long-Term Treatment Against Cirrhosis Trial, a nested case-control study of 39 HCC cases (24 early stage) and 77 matched controls was conducted to compare the performance of AFP and DCP. Testing was performed on serial serum samples collected during a 12-month period prior to the time of HCC diagnosis. Study results indicated that:

  • The sensitivity and specificity of DCP at month 0 (at the time of HCC diagnosis) was 74 percent and 86 percent at a cutoff of 40 mAU/mL, and 43 percent and 100 percent at a cutoff of 150 mAU/mL.
  • The sensitivity and specificity of AFP at month 0 was 61 percent and 81 percent at a cutoff of 20 ng/mL, and 22 percent and 100 percent at a cutoff of 200 ng/mL.
  • At month -12 (12 months before the diagnosis of HCC), the sensitivity and specificity at the low cutoff was 43 percent and 94 percent for DCP, and 47 percent and 75 percent for AFP.
  • Combining both markers increased the sensitivity to 91 percent at month 0 and 73 percent at month -12, but the specificity decreased to 74 percent and 71 percent.

DCP was not superior to AFP in the early detection of HCC in patients with advanced hepatitis C and neither AFP alone, DCP alone, nor the combination of AFP and DCP was sufficiently accurate to be used for HCC surveillance. The combination of both markers enhanced the sensitivity, indicating that these two markers are complementary. Therefore, prospective studies should be conducted to determine if combining both markers will improve the detection of early HCC and to establish the optimal cutoff values that should be used for patient recall and further testing.

"Until better serum markers are available, ultrasonography remains the preferred tool for HCC surveillance. However, reliable biomarkers to complement ultrasound may improve the detection of early HCC in clinical practice where interpretation of ultrasound is variable," added Dr. Lok; in this study, diagnosis of early HCC was triggered by surveillance ultrasound in only 58 percent of patients.

Liver cancer is the sixth most common malignancy and the third most common cause of cancer-related death worldwide. The incidence of HCC in the U.S. is increasing and is largely attributed to hepatitis C. While the survival of patients with most malignancies has improved over the last decade, five-year survival of patients with HCC has remained less than 10 percent. The poor outcome of patients with HCC is related to late detection with more than two-thirds of patients diagnosed at advanced stages of disease. A major problem with HCC surveillance is the lack of reliable biomarkers. While AFP is the most widely used biomarker for HCC surveillance, experience with DCP is limited.


'/>"/>

Contact: Alissa J. Cruz
media@gastro.org
301-272-1603
American Gastroenterological Association
Source:Eurekalert

Related medicine news :

1. Atrion Networking Corporation Selects Ruckus Wireless for Reliable as Wire Enterprise Wi-Fi Service
2. NetMotion Wireless Publishes New Healthcare White Paper: Secure, Reliable Connections for Better Patient Care
3. Studies Find PSA Screening Unreliable
4. FaxSIPit and FaxBack Announce Partnership To Bring Reliable VoIP Fax to Service Providers
5. Kansas City Patients Rate Their Doctors in Most Reliable Survey of Its Kind
6. Headache Sufferers Turn to Neurologychannel for Reliable Information about New Headache Treatments
7. Medgateway.com Provides a Gateway to Reliable Health and Medical Information on the Internet.
8. Study finds that using wakefulness tests to detect daytime sleepiness in drivers may be unreliable
9. That gut feeling may actually reflect a reliable memory
10. www.greatplacesinc.com Isthe Leading Internet Resourcefor Current, Relevant, Reliable Advice,Counseling the 76 MillionBaby Boomers Who Are Increasingly Responsible for Their Aging Parents' Care
11. Risk assessment tool not reliable predictor for some women at high risk of breast cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... York, NY (PRWEB) , ... April 28, 2017 ... ... Medical Laboratory to expanded distribution of the GlycoMark test throughout the Northeast U.S. ... recent hyperglycemia in patients with diabetes. The GlycoMark test provides a clinically proven ...
(Date:4/28/2017)... ... April 28, 2017 , ... The Radiology Business Management Association (RBMA) ... The annual board election process has been in place since the RBMA was founded ... Dickerson, Ed.D., FACHE, succeeds Jim Hamilton, MHA, CMM, FRBMA, as president. Dr. Dickerson the ...
(Date:4/28/2017)... Texas (PRWEB) , ... April 28, 2017 , ... The ... plaque in recently to the labor and delivery team at Women’s Hospital at Renaissance ... mothers who give birth at the hospital and decide to donate. , “Women’s ...
(Date:4/28/2017)... ... April 28, 2017 , ... People are starting to accept that hearing ... aid doesn’t have the stigma it had when great-grandpa wore his hearing aids years ... in a NALA North American Speaker Series (NASS) segment. “He probably wore ...
(Date:4/28/2017)... ... April 28, 2017 , ... Researchers at ... of ActiGraph’s CentrePoint Data Hub in a sample of participants enrolled ... wearable activity and sleep monitoring solutions for the global scientific community. The company’s ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... Research and Markets has announced the addition ... Addressing Production Complexities Through Risk Management and Quality by ... ... Market Prospects: Overcoming Production Complexities Through Risk Management and ... current trends in the global biosimilars market, with a ...
(Date:4/20/2017)... Research and Markets has announced the addition ... Rapidly Expanding Injectables Market and Increasing Usage of Complex Biologics during ... ... rise from USD 20 Billion in 2015 to around USD 26 ... - Innovation Driven by Rapidly Expanding Injectables Market and Increasing Usage ...
(Date:4/20/2017)... Inc ., a digital health company focused on modernizing and ... $25 million in Series B funding led by Qiming US ... Seattle that is part of a broader family ... included participation from SR One , who led ZappRx,s ... Google Ventures). As part of the financing, Mark McDade ...
Breaking Medicine Technology: